[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"transfusion-reaction\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:transfusion-reaction":90},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,51,74],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":20,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":32,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100547068",false,"NCT06403163","Transfusion Surveillance in Anaesthesia","Biological Transfusion Efficiency Registry Transfusion Surveillance in Anaesthesia","STAR","Inclusion Criteria:\n\n* all patients who have received an hemostasis product\n\nExclusion Criteria:\n\n* patient who refused to consent to data analysis and study participation","ALL",{"count":18,"type":19},50000,"ESTIMATED","2 Weeks","OBSERVATIONAL","the aim of this register is to collect exhaustively the different data available surrounding a transfusion act in the context of an active haemorrhage. The aim is to allow different modelling and analysis related to emergency transfusion.",[24,25,26,27,28,29,30,31],"Transfusion Reaction","Transfusion Related Complication","Anesthesia","Anesthesia; Shock","Side Effect","Fresh Blood Stool","Blood Coagulation Disorder","Blood Loss",[33,34,35,36,37],"transfusion","monitoring","emergency situation","shock","fresh frozen plasma","RECRUITING","2025-08-25",{"date":41,"type":42},"2025-09-02","ACTUAL",{"date":44,"type":42},"2022-09-01",{"date":46,"type":19},"2030-12-31",{"name":48,"class":49},"Erasme University Hospital","OTHER",1,{"id":52,"slug":4,"hasResults":10,"nctId":53,"briefTitle":54,"officialTitle":54,"acronym":4,"eligibilityCriteria":55,"healthyVolunteers":10,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":56,"targetDuration":4,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":4,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":50},"100558892","NCT06557031","Clinical Performance Study of the ABTest Card® Device.","Inclusion Criteria:\n\n* Age ≥ 18 years old for the category marked with \\*.\n* Undergo capillary blood sampling ;\n* Belong to one of the clinical categories:\n* Patient in need of blood transfusion without any pathology known to have an impact on transfusion act\\* ;\n* Patient in need of blood transfusion suffering from congenital erythrocyte pathology (sickle cell anaemia, beta thalassemia)\\* ;\n* Patient in need of blood transfusion suffering from haematology disease (e.g. cancer), or undergoing haemodialysis\\* ;\n* Patient with cold agglutinin\\* ;\n* Premature patient with gestational age \\\u003C 37 weeks or newborn ≤27 days old in need of blood transfusion ;\n* Newborn eligible for the Guthrie Test ;\n* Newborn eligible for the glycaemic test.\n* Have health care insurance ;\n* Have given his\u002Fher written consent (or legal representative in the case of a newborn) ;\n\nExclusion Criteria:\n\n* Pregnant woman ;\n* Person deprived of liberty ;\n* Unconscious person ;\n* Person under guardianship or trusteeship ;\n* For paediatric clinical category: age ≥28 days and \\\u003C18 years old.",{"count":57,"type":19},200,"INTERVENTIONAL",[60],"NA","The study aims to confirm the performance equivalence of the in vitro diagnostic device ABTest Card®REF with the ABTest Card®NEW device.",[24],"NOT_YET_RECRUITING","2024-08-13",{"date":66,"type":42},"2024-08-16",{"date":68,"type":19},"2024-09",{"date":70,"type":19},"2025-01",{"name":72,"class":73},"Diagast","INDUSTRY",{"id":75,"slug":4,"hasResults":10,"nctId":76,"briefTitle":77,"officialTitle":77,"acronym":4,"eligibilityCriteria":78,"healthyVolunteers":10,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":79,"targetDuration":4,"studyType":58,"phases":81,"briefSummary":82,"conditions":83,"keywords":4,"overallStatus":63,"whyStopped":4,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":87,"completionDateStruct":88,"leadSponsor":89,"locationsCount":50},"100557873","NCT06543771","Clinical Performance Study of Safety Test ABO Device","Inclusion Criteria:\n\n* Age ≥ 18 years old for the category marked with \\*.\n* Undergo capillary blood sampling;\n* Belong to one of the clinical category:\n\n  * Patient in need of blood transfusion without any pathology known to have an impact on transfusion act\\*;\n  * Patient in need of blood transfusion suffering from congenital erythrocyte pathology (sickle cell anaemia, beta thalassemia)\\*\n  * Patient in need of blood transfusion suffering from haematology disease (eg. cancer), or undergoing haemodialysis\\*;\n  * Patient with cold agglutinin\\*;\n  * Premature patient with gestational age \\\u003C 37 weeks of newborn ≤27 days old in need of blood transfusion;\n  * Newborn eligible for Guthrie Test;\n  * Newborn eligible for glycemic test.\n* Have health care insurance;\n* Have given his\u002Fher written consent (or legal representative in case of newborn);\n\nExclusion Criteria:\n\n* Pregnant woman;\n* Person deprived of liberty;\n* Unconscious person;\n* Person under guardianship or trusteeship;\n* For neonatal clinical category: age ≥28 days and \\\u003C18 years old.",{"count":80,"type":19},100,[60],"The study aims to confirm the performance equivalence of the in vitro diagnostic device Safety Test ABO with the ABTest Card device.",[24],"2024-08-06",{"date":86,"type":42},"2024-08-09",{"date":68,"type":19},{"date":70,"type":19},{"name":72,"class":73},""]